Section 35AC project approval: tax deduction cap set for an approved medical research project over three financial years. Notification under section 35AC approves Thrombosis Research Institute to carry an approved project-development of a recombinant DNA vaccine and a low cost urine test-and specifies the project's estimated cost and the cumulative maximum amount of that cost allowable as a deduction under section 35AC for the three specified financial years.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Section 35AC project approval: tax deduction cap set for an approved medical research project over three financial years.
Notification under section 35AC approves Thrombosis Research Institute to carry an approved project-development of a recombinant DNA vaccine and a low cost urine test-and specifies the project's estimated cost and the cumulative maximum amount of that cost allowable as a deduction under section 35AC for the three specified financial years.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.